Erratum: Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients' ( Future Oncology (2015) 11:6 (965-973) DOI: 10.2217/fon.14.284)

Orazio Caffo, Giovanni Lo Re, Teodoro Sava, Sebastiano Buti, Cosimo Sacco, Umberto Basso, Fable Zustovich, Michele Lodde, Alessandra Perin, Gaetano Facchini, Antonello Veccia, Francesca Maines, Carmen Barile, Lucia Fratino, Angela Gernone, Rocco De Vivo, Giovanni L. Pappagallo, Enzo Galligioni

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1845
Number of pages1
JournalFuture Oncology
Volume11
Issue number12
DOIs
Publication statusPublished - Jun 1 2015

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Erratum : Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients' ( Future Oncology (2015) 11:6 (965-973) DOI: 10.2217/fon.14.284). / Caffo, Orazio; Lo Re, Giovanni; Sava, Teodoro; Buti, Sebastiano; Sacco, Cosimo; Basso, Umberto; Zustovich, Fable; Lodde, Michele; Perin, Alessandra; Facchini, Gaetano; Veccia, Antonello; Maines, Francesca; Barile, Carmen; Fratino, Lucia; Gernone, Angela; De Vivo, Rocco; Pappagallo, Giovanni L.; Galligioni, Enzo.

In: Future Oncology, Vol. 11, No. 12, 01.06.2015, p. 1845.

Research output: Contribution to journalArticle

Caffo, O, Lo Re, G, Sava, T, Buti, S, Sacco, C, Basso, U, Zustovich, F, Lodde, M, Perin, A, Facchini, G, Veccia, A, Maines, F, Barile, C, Fratino, L, Gernone, A, De Vivo, R, Pappagallo, GL & Galligioni, E 2015, 'Erratum: Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients' ( Future Oncology (2015) 11:6 (965-973) DOI: 10.2217/fon.14.284)', Future Oncology, vol. 11, no. 12, pp. 1845. https://doi.org/10.2217/fon.15.100
Caffo, Orazio ; Lo Re, Giovanni ; Sava, Teodoro ; Buti, Sebastiano ; Sacco, Cosimo ; Basso, Umberto ; Zustovich, Fable ; Lodde, Michele ; Perin, Alessandra ; Facchini, Gaetano ; Veccia, Antonello ; Maines, Francesca ; Barile, Carmen ; Fratino, Lucia ; Gernone, Angela ; De Vivo, Rocco ; Pappagallo, Giovanni L. ; Galligioni, Enzo. / Erratum : Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients' ( Future Oncology (2015) 11:6 (965-973) DOI: 10.2217/fon.14.284). In: Future Oncology. 2015 ; Vol. 11, No. 12. pp. 1845.
@article{f025ca886a9444f89f4b8ae752c7d462,
title = "Erratum: Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients' ( Future Oncology (2015) 11:6 (965-973) DOI: 10.2217/fon.14.284)",
author = "Orazio Caffo and {Lo Re}, Giovanni and Teodoro Sava and Sebastiano Buti and Cosimo Sacco and Umberto Basso and Fable Zustovich and Michele Lodde and Alessandra Perin and Gaetano Facchini and Antonello Veccia and Francesca Maines and Carmen Barile and Lucia Fratino and Angela Gernone and {De Vivo}, Rocco and Pappagallo, {Giovanni L.} and Enzo Galligioni",
year = "2015",
month = "6",
day = "1",
doi = "10.2217/fon.15.100",
language = "English",
volume = "11",
pages = "1845",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "12",

}

TY - JOUR

T1 - Erratum

T2 - Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients' ( Future Oncology (2015) 11:6 (965-973) DOI: 10.2217/fon.14.284)

AU - Caffo, Orazio

AU - Lo Re, Giovanni

AU - Sava, Teodoro

AU - Buti, Sebastiano

AU - Sacco, Cosimo

AU - Basso, Umberto

AU - Zustovich, Fable

AU - Lodde, Michele

AU - Perin, Alessandra

AU - Facchini, Gaetano

AU - Veccia, Antonello

AU - Maines, Francesca

AU - Barile, Carmen

AU - Fratino, Lucia

AU - Gernone, Angela

AU - De Vivo, Rocco

AU - Pappagallo, Giovanni L.

AU - Galligioni, Enzo

PY - 2015/6/1

Y1 - 2015/6/1

UR - http://www.scopus.com/inward/record.url?scp=84931315109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931315109&partnerID=8YFLogxK

U2 - 10.2217/fon.15.100

DO - 10.2217/fon.15.100

M3 - Article

AN - SCOPUS:84931315109

VL - 11

SP - 1845

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 12

ER -